Men's Health

There was no impairment of fertility in rats given sildenafil up to 60 mg/kg/day for 36 days to females and 102 days to males, a dose producing an AUC value of more than 25 times the human male AUC.

4.3 Concomitant Guanylate Cyclase (GC) Stimulators

The titration studies, in which most patients received 100 mg, showed similar results. Figure 6 shows that regardless of the baseline levels of function, subsequent function in patients treated with sildenafil was better than that seen in patients treated with placebo. At the same time, on-treatment function was better in treated patients who were less impaired at baseline.The frequency of patients reporting improvement of erections in response to a global question in four of the randomized, double-blind, parallel, placebo-controlled fixed dose studies (1797 patients) of 12 to 24 weeks duration is shown in Figure 7. These patients had erectile dysfunction at baseline that was characterized by median categorical scores of 2 (a few times) on principal IIEF questions. Erectile dysfunction was attributed to organic (58%; generally not characterized, sildenafil products over the counter but including diabetes and excluding spinal cord injury), psychogenic (17%), or mixed (24%) etiologies.

What is sildenafil used for?

Sixty-three percent, 74%, and 82% of the patients on 25 mg, 50 mg and 100 mg of sildenafil, respectively, reported an improvement in their erections, compared to 24% on placebo. In the titration studies (n=644) (with most patients eventually receiving 100 mg), results were similar.The patients in studies had varying degrees of ED. One-third to one-half of the subjects in these studies reported successful intercourse at least once during a 4-week, treatment-free run-in period.In many of the studies, of both fixed dose and titration designs, daily diaries were kept by patients. In these studies, involving about 1600 patients, analyses of patient diaries showed no effect of sildenafil on rates of attempted intercourse (about 2 per week), but there was clear treatment-related improvement in sexual function: per patient weekly success rates averaged 1.3 on 50 to 100 mg of sildenafil vs 0.4 on placebo; similarly, group mean success rates (total successes divided by total attempts) were about 66% on sildenafil vs about 20% on placebo.During 3 to 6 months of double-blind treatment or longer-term (1 year), open-label studies, few patients withdrew from active treatment for any reason, including lack of effectiveness. At the end of the long-term study, 88% of patients reported that sildenafil improved their erections.Men with untreated ED had relatively low baseline scores for all aspects of sexual function measured (again using a 5-point scale) in the IIEF.

Dosage forms

Sildenafil improved these aspects of sexual function: frequency, firmness and maintenance of erections; frequency of orgasm; frequency and level of desire; frequency, satisfaction and enjoyment of intercourse; and overall relationship satisfaction.One randomized, double-blind, flexible-dose, placebo-controlled study included only patients with erectile dysfunction attributed to complications of diabetes mellitus (n=268). As in the other titration studies, patients were started on 50 mg and allowed to adjust the dose up to 100 mg or down to 25 mg of sildenafil; all patients, however, were receiving 50 mg or 100 mg at the end of the study. There were highly statistically significant improvements on the two principal IIEF questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) on sildenafil compared to placebo. On a global improvement question, 57% of sildenafil patients reported improved erections versus 10% on placebo. Diary data indicated that sildenafil oral jelly 100mg on sildenafil, 48% of intercourse attempts were successful versus 12% on placebo.One randomized, double-blind, placebo-controlled, crossover, flexible-dose (up to 100 mg) study of patients with erectile dysfunction resulting from spinal cord injury (n=178) was conducted. 14 CLINICAL STUDIES In clinical studies, sildenafil was assessed for its effect on the ability of men with erectile dysfunction (ED) to engage in sexual activity and in many cases specifically on the ability to achieve and maintain an erection sufficient for satisfactory sexual activity. Sildenafil was evaluated primarily at doses of 25 mg, 50 mg and 100 mg in 21 randomized, double-blind, placebo-controlled trials of up to 6 months in duration, using a variety of study designs (fixed dose, titration, parallel, crossover). Sildenafil was administered to more than 3,000 patients aged 19 to 87 years, with ED of various etiologies (organic, psychogenic, mixed) with a mean duration of 5 years.

Product	Dosage	Quantity + Bonus	Price
Kamagra Polo	100mg	180 + 8 Pills	446.52€ 425.26€	Buy
Viagra Generic	100mg	20 Pills	45.58€ 43.41€	Buy
Viagra Generic	200mg	270 + 10 Pills	379.76€ 361.68€	Buy
Kamagra Oral Jelly	100mg	110 + 9 Sachets	334.87€ 318.92€	Buy
Kamagra Soft Tabs	100mg	32 Pills	120.11€ 114.39€	Buy
Viagra Generic	150mg	180 + 10 Pills	236.46€ 225.20€	Buy
Viagra Generic	50mg	60 + 4 Pills	83.93€ 79.93€	Buy
Viagra Generic	50mg	180 + 8 Pills	158.82€ 151.26€	Buy
Viagra Generic	50mg	90 + 6 Pills	107.37€ 102.26€	Buy
Viagra Generic	150mg	120 + 8 Pills	177.58€ 169.12€	Buy
Viagra Generic	200mg	60 + 4 Pills	125.19€ 119.23€	Buy
Kamagra	100mg	20 Pills	86.09€ 81.99€	Buy
Viagra Generic	100mg	120 + 6 Pills	149.50€ 142.38€	Buy

Sildenafil demonstrated statistically significant improvement compared to placebo in all 21 studies.

• Sildenafil white is sometimes called the "blue pill" in popular culture.
• It remains one of the most prescribed medications for ED worldwide.
• Some individuals purchase sildenafil white without a prescription, which can be risky.
• Derived from a scientific discovery initially aimed at heart treatment.
• Viagra was the first brand to market sildenafil for ED.
• The medication can cause side effects like dizziness and upset stomach.
• Elderly patients should be cautious due to increased risk of side effects.
• Regular medical check-ups are recommended for long-term sildenafil users.
• Lifestyle changes, such as exercise and diet, can enhance treatment results.
• The medication is typically taken on an empty stomach for quicker effect.
• Research continues into new formulations and delivery methods for sildenafil

The studies that established benefit demonstrated improvements in success rates for sexual intercourse compared with placebo.Efficacy Endpoints in Controlled Clinical StudiesThe effectiveness of sildenafil was evaluated in most studies using several assessment instruments. The primary measure in the principal studies was a sexual function questionnaire (the International Index of Erectile Function - IIEF) administered during a 4-week treatment-free run-in period, at baseline, at follow-up visits, and at the end of double-blind, placebo-controlled, at-home treatment. Two of the questions from the IIEF served as primary study endpoints; categorical responses were elicited to questions about (1) the ability to achieve erections sufficient for sexual intercourse and (2) the maintenance of erections after penetration. The patient addressed both questions at the final visit for the last sildenafil 100 mg tab 4 weeks of the study. The possible categorical responses to these questions were (0) no attempted intercourse, (1) never or almost never, (2) a few times, (3) sometimes, (4) most times, and (5) almost always or always. Also collected as part of the IIEF was information about other aspects of sexual function, including information on erectile function, orgasm, desire, satisfaction with intercourse, and overall sexual satisfaction. Sexual function data were also recorded by patients in a daily diary. In addition, patients were asked a global efficacy question and an optional partner questionnaire was administered.Efficacy Results from Controlled Clinical StudiesThe effect on one of the major end points, maintenance of erections after penetration, is shown in Figure 6, for the pooled results of 5 fixed-dose, dose-response studies of greater than one month duration, showing response according to baseline function. Results with all doses have been pooled, but scores showed greater improvement at the 50 and 100 mg doses than at 25 mg.

Condition	Risk	Recommendation
Nitrate Use	Severe hypotension	Avoid combination
Heart Disease	Increased risk of cardiac event	Consult physician
Liver or Kidney Impairment	Altered drug metabolism	Dose adjustment necessary
Retinitis Pigmentosa	Potential for increased visual side effects	Use with caution

The pattern of responses was similar for the other principal question, the ability to achieve an erection sufficient for intercourse.

• The term 'sildenafil white' often refers to unbranded, generic pills.
• It may be available online through various pharmacies and vendors.
• Users should verify the legitimacy of sildenafil sources to avoid fake products.
• This medication is not suitable for individuals with certain heart conditions.
• Sildenafil white is sometimes used recreationally for its euphoric effects.
• It may interact with certain antibiotics and antifungals, altering effectiveness.
• Patients should inform their doctor of all medications before use.
• The medication is not an aphrodisiac; it only facilitates erectile response.
• Overuse or misuse of sildenafil white can lead to serious health risks.
• The recommended maximum frequency is once per day unless advised otherwise.
• Consultation with a healthcare professional is essential prior to use.

The titration studies, in which most patients received 100 mg, showed similar results. Figure 6 shows that regardless of the baseline levels of function, subsequent function in patients treated with sildenafil was better than that seen in patients treated with placebo.

5.1 Hypotension

At the same time, on-treatment function was better in treated patients who were less impaired at baseline.The frequency of patients reporting improvement of erections in response to a global question in four of the randomized, double-blind, parallel, placebo-controlled fixed dose studies (1797 patients) of 12 to 24 weeks duration is shown in Figure 7. These patients had erectile dysfunction at baseline that was characterized by median categorical scores of 2 (a few times) on principal IIEF questions.

Warnings & Precautions

There was no impairment of fertility in rats given sildenafil up to 60 mg/kg/day for 36 days to females and 102 days to males, a dose producing an AUC value of more than 25 times the human male AUC. 14 CLINICAL STUDIES In clinical studies, sildenafil was assessed for its effect on the ability of men with erectile dysfunction (ED) to engage in sexual activity and in many cases specifically on the ability to achieve and maintain an erection sufficient for satisfactory sexual activity. Sildenafil was evaluated primarily at doses of 25 mg, 50 mg and 100 mg in 21 randomized, double-blind, placebo-controlled trials of up to 6 months in duration, using a variety of study designs (fixed dose, titration, parallel, crossover). Sildenafil was administered to more than 3,000 patients aged 19 to 87 years, with ED of various etiologies (organic, psychogenic, mixed) with a mean duration of 5 years. Sildenafil demonstrated statistically significant improvement compared to placebo in all 21 studies.

Priligy Generic Dapoxetine

The studies that established benefit demonstrated improvements in success rates for sexual intercourse compared with placebo.Efficacy Endpoints in Controlled Clinical StudiesThe effectiveness of sildenafil was evaluated in most studies using several assessment instruments. The primary measure in the principal studies was a sexual function questionnaire (the International Index of Erectile Function - IIEF) administered during a 4-week treatment-free run-in period, at baseline, at follow-up visits, and at the end of double-blind, placebo-controlled, at-home treatment. Two of the questions from the IIEF served as primary study endpoints; categorical responses were elicited to questions about (1) the ability to achieve erections sufficient for sexual intercourse and (2) the maintenance of erections after penetration. The patient addressed both questions at the final visit for the last sildenafil 100 mg tab 4 weeks of the study. The possible categorical responses to these questions were (0) no attempted intercourse, (1) never or almost never, (2) a few times, (3) sometimes, (4) most times, and (5) almost always or always.

Who should not take sildenafil?

Also collected as part of the IIEF was information about other aspects of sexual function, including information on erectile function, orgasm, desire, satisfaction with intercourse, and overall sexual satisfaction. Sexual function data were also recorded by patients in a daily diary. In addition, patients were asked a global efficacy question and an optional partner questionnaire was administered.Efficacy Results from Controlled Clinical StudiesThe effect on one of the major end points, maintenance of erections after penetration, is shown in Figure 6, for the pooled results of 5 fixed-dose, dose-response studies of greater than one month duration, showing response according to baseline function. Results with all doses have been pooled, but scores showed greater improvement at the 50 and 100 mg doses than at 25 mg. The pattern of responses was similar for the other principal question, the ability to achieve an erection sufficient for intercourse. Erectile dysfunction was attributed to organic (58%; generally not characterized, sildenafil products over the counter but including diabetes and excluding spinal cord injury), psychogenic (17%), or mixed (24%) etiologies. Sixty-three percent, 74%, and 82% of the patients on 25 mg, 50 mg and 100 mg of sildenafil, respectively, reported an improvement in their erections, compared to 24% on placebo.

5.1 Cardiovascular

The changes from baseline in scoring on the two end point questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) were highly statistically significantly in favor of sildenafil. On a global improvement question, 83% of patients reported improved erections on sildenafil versus 12% on placebo. Diary data indicated that on sildenafil, 59% of attempts at sexual intercourse were successful compared to 13% on placebo.Across all trials, sildenafil improved the erections of 43% of radical prostatectomy patients compared to 15% on placebo.Subgroup analyses of responses to a global improvement question in patients with psychogenic etiology in two fixed-dose studies (total n=179) and two titration studies (total n=149) showed 84% of sildenafil patients reported improvement in erections compared with 26% of placebo. Diary data in two of the studies (n=178) showed rates of successful intercourse per attempt of 70% for sildenafil and 29% for placebo.Efficacy Results in Subpopulations in Controlled Clinical StudiesA review of population subgroups demonstrated efficacy regardless of baseline severity, etiology, race and age. Sildenafil was effective in a broad range of ED patients, including those with a history of coronary artery disease, hypertension, other cardiac disease, peripheral vascular disease, diabetes mellitus, depression, coronary artery bypass graft (CABG), radical prostatectomy, transurethral resection of the prostate (TURP) and spinal cord injury, and in patients taking antidepressants/antipsychotics and anti-hypertensives/diuretics.

Fildena Super Active

16 HOW SUPPLIED/STORAGE AND HANDLING Sildenafil Tablets USP, 25 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘28’ on the other side.Bottles of 30 NDC 65862-689-30Bottles of 100 NDC 65862-689-01Bottles of 500 NDC 65862-689-05Bottles of 1,000 NDC 65862-689-99Sildenafil Tablets USP, 50 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘29’ on the other side.Bottles of 30 NDC 65862-690-30Bottles of 100 NDC 65862-690-01Bottles of 500 NDC 65862-690-05Bottles of 1,000 NDC 65862-690-99Sildenafil Tablets USP, 100 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘30’ on the other side.Bottles of 30 NDC 65862-691-30Bottles of 100 NDC 65862-691-01Bottles of 500 NDC 65862-691-05Recommended Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Sildenafil Tablets USP, 25 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘28’ on the other side. Bottles of 30 NDC 65862-689-30 Bottles of 100 NDC 65862-689-01 Bottles of 500 NDC 65862-689-05 Bottles of 1,000 NDC 65862-689-99 Sildenafil Tablets USP, 50 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘29’ on the other side. Bottles of 30 NDC 65862-690-30 Bottles of 100 NDC 65862-690-01 Bottles of 500 NDC 65862-690-05 Bottles of 1,000 NDC 65862-690-99 Sildenafil Tablets USP, 100 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘30’ on the other side.

Teva sildenafil pills are white, not blue

In the titration studies (n=644) (with most patients eventually receiving 100 mg), results were similar.The patients in studies had varying degrees of ED. One-third to one-half of the subjects in these studies reported successful intercourse at least once during a 4-week, treatment-free run-in period.In many of the studies, of both fixed dose and titration designs, daily diaries were kept by patients. In these studies, involving about 1600 patients, analyses of patient diaries showed no effect of sildenafil on rates of attempted intercourse (about 2 per week), but there was clear treatment-related improvement in sexual function: per patient weekly success rates averaged 1.3 on 50 to 100 mg of sildenafil vs 0.4 on placebo; similarly, group mean success rates (total successes divided by total attempts) were about 66% on sildenafil vs about 20% on placebo.During 3 to 6 months of double-blind treatment or longer-term (1 year), open-label studies, few patients withdrew from active treatment for any reason, including lack of effectiveness. At the end of the long-term study, 88% of patients reported that sildenafil improved their erections.Men with untreated ED had relatively low baseline scores for all aspects of sexual function measured (again using a 5-point scale) in the IIEF.

• Sildenafil white was first approved by the FDA in 1998.
• It is marketed under various brand and generic names worldwide.
• The drug belongs to a class called phosphodiesterase inhibitors.
• It is effective for many men with both physical and psychological ED.
• Sildenafil white may also help treat pulmonary arterial hypertension.
• Some users report experiencing visual disturbances after taking it.
• The medication’s effects last approximately 4 to 6 hours.
• It is advisable to avoid alcohol when taking sildenafil white.
• Consumers should check for potential drug allergies before use.
• The pill's color and shape can vary depending on the manufacturer.
• Always consult a healthcare provider for appropriate use and dosing.

Sildenafil improved these aspects of sexual function: frequency, firmness and maintenance of erections; frequency of orgasm; frequency and level of desire; frequency, satisfaction and enjoyment of intercourse; and overall relationship satisfaction.One randomized, double-blind, flexible-dose, placebo-controlled study included only patients with erectile dysfunction attributed to complications of diabetes mellitus (n=268). As in the other titration studies, patients were started on 50 mg and allowed to adjust the dose up to 100 mg or down to 25 mg of sildenafil; all patients, however, were receiving 50 mg or 100 mg at the end of the study. There were highly statistically significant improvements on the two principal IIEF questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) on sildenafil compared to placebo. On a global improvement question, 57% of sildenafil patients reported improved erections versus 10% on placebo. Diary data indicated that sildenafil oral jelly 100mg on sildenafil, 48% of intercourse attempts were successful versus 12% on placebo.One randomized, double-blind, placebo-controlled, crossover, flexible-dose (up to 100 mg) study of patients with erectile dysfunction resulting from spinal cord injury (n=178) was conducted. The changes from baseline in scoring on the two end point questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) were highly statistically significantly in favor of sildenafil. On a global improvement question, 83% of patients reported improved erections on sildenafil versus 12% on placebo. Diary data indicated that on sildenafil, 59% of attempts at sexual intercourse were successful compared to 13% on placebo.Across all trials, sildenafil improved the erections of 43% of radical prostatectomy patients compared to 15% on placebo.Subgroup analyses of responses to a global improvement question in patients with psychogenic etiology in two fixed-dose studies (total n=179) and two titration studies (total n=149) showed 84% of sildenafil patients reported improvement in erections compared with 26% of placebo.

• Sildenafil white is often sold as small, round, white tablets.
• It is available in various formulations, including sublingual and capsules.
• The drug increases cGMP levels, leading to smooth muscle relaxation.
• Generic sildenafil is usually cheaper than brand-name Viagra.
• Erectile dysfunction can be caused by physical or mental health issues.
• Misusing sildenafil white can result in priapism, a painful erection lasting hours.
• Some formulations come with flavoring to improve taste.
• Patient education about correct use is key to safety and effectiveness.
• Sildenafil white does not protect against sexually transmitted infections.
• It is important to avoid taking more than the recommended dose.
• Long-term safety data is still being studied, but generally considered safe when used properly.

Diary data in two of the studies (n=178) showed rates of successful intercourse per attempt of 70% for sildenafil and 29% for placebo.Efficacy Results in Subpopulations in Controlled Clinical StudiesA review of population subgroups demonstrated efficacy regardless of baseline severity, etiology, race and age. Sildenafil was effective in a broad range of ED patients, including those with a history of coronary artery disease, hypertension, other cardiac disease, peripheral vascular disease, diabetes mellitus, depression, coronary artery bypass graft (CABG), radical prostatectomy, transurethral resection of the prostate (TURP) and spinal cord injury, and in patients taking antidepressants/antipsychotics and anti-hypertensives/diuretics. 16 HOW SUPPLIED/STORAGE AND HANDLING Sildenafil Tablets USP, 25 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘28’ on the other side.Bottles of 30 NDC 65862-689-30Bottles of 100 NDC 65862-689-01Bottles of 500 NDC 65862-689-05Bottles of 1,000 NDC 65862-689-99Sildenafil Tablets USP, 50 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘29’ on the other side.Bottles of 30 NDC 65862-690-30Bottles of 100 NDC 65862-690-01Bottles of 500 NDC 65862-690-05Bottles of 1,000 NDC 65862-690-99Sildenafil Tablets USP, 100 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘30’ on the other side.Bottles of 30 NDC 65862-691-30Bottles of 100 NDC 65862-691-01Bottles of 500 NDC 65862-691-05Recommended Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Sildenafil Tablets USP, 25 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘28’ on the other side. Bottles of 30 NDC 65862-689-30 Bottles of 100 NDC 65862-689-01 Bottles of 500 NDC 65862-689-05 Bottles of 1,000 NDC 65862-689-99 Sildenafil Tablets USP, 50 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘29’ on the other side. Bottles of 30 NDC 65862-690-30 Bottles of 100 NDC 65862-690-01 Bottles of 500 NDC 65862-690-05 Bottles of 1,000 NDC 65862-690-99 Sildenafil Tablets USP, 100 mg are white to off-white, diamond shaped, biconvex, film-coated tablets debossed with ‘T’ on one side and ‘30’ on the other side.